Photothermal Therapy Technology of Metastatic Colorectal Cancer

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2020 Aug 11

PMID 32774688

Citations 12

Authors

Junji Chen

Ziwei Zeng

Liang Huang

Shuangling Luo

Jianghui Dong

Fiona H Zhou

Kun Zhou

Liping Wang

Liang Kang

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is one of the most common malignancies. The current treatments of metastatic colorectal cancer (mCRC) are ineffective and the bottleneck problem. It is of significance to explore effective new therapeutic strategies to eradicate mCRC. Photothermal therapy (PTT) is an emerging technology for tumor therapy, with the potential in the treatment of mCRC. In this review, the current treatment approaches to mCRC including surgery, radiotherapy, chemotherapy interventional therapy, biotherapy, and photothermal therapy are reviewed. In addition, we will focus on the various kinds of nanomaterials used in PTT for the treatment of CRC both in vitro and in vivo models. In conclusion, we will summarize the combined application of PTT with other theranostic methods, and propose future research directions of PTT in the treatment of CRC.

Citing Articles

Multi-modal triggered-release sonodynamic/chemo/phototherapy synergistic nanocarriers for the treatment of colon cancer.

Zhou Y, Gao Y, Yao N, Lu G, Dong C, Wang K Front Bioeng Biotechnol. 2024; 12:1439883.

PMID: 39104624 PMC: 11298370. DOI: 10.3389/fbioe.2024.1439883.

Progress and Perspectives in Colon Cancer Pathology, Diagnosis, and Treatments.

Alrushaid N, Khan F, Al-Suhaimi E, Elaissari A Diseases. 2023; 11(4).

PMID: 37987259 PMC: 10660546. DOI: 10.3390/diseases11040148.

Nanoparticles for imaging-guided photothermal therapy of colorectal cancer.

Farzam O, Mehran N, Bilan F, Aghajani E, Dabbaghipour R, Asemani Shahgoli G Heliyon. 2023; 9(11):e21334.

PMID: 37920521 PMC: 10618772. DOI: 10.1016/j.heliyon.2023.e21334.

New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy.

Freitas S, Sanderson D, Caspani S, Magalhaes R, Cortes-Llanos B, Granja A Cancers (Basel). 2023; 15(2).

PMID: 36672333 PMC: 9856291. DOI: 10.3390/cancers15020383.

Light-activated nanomaterials for tumor immunotherapy.

Wang F, Duan H, Xu W, Sheng G, Sun Z, Chu H Front Chem. 2022; 10:1031811.

PMID: 36277335 PMC: 9585221. DOI: 10.3389/fchem.2022.1031811.

References

Levi-Polyachenko N, Merkel E, Jones B, Carroll D, Stewart 4th J . Rapid photothermal intracellular drug delivery using multiwalled carbon nanotubes. Mol Pharm. 2009; 6(4):1092-9. DOI: 10.1021/mp800250e. View

Austin H, Henley S, King J, Richardson L, Eheman C . Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening. Cancer Causes Control. 2013; 25(2):191-201. PMC: 4394895. DOI: 10.1007/s10552-013-0321-y. View

Pressly E, Rossin R, Hagooly A, Fukukawa K, Messmore B, Welch M . Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers. Biomacromolecules. 2007; 8(10):3126-34. DOI: 10.1021/bm700541e. View

Franko J, Shi Q, Meyers J, Maughan T, Adams R, Seymour M . Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016; 17(12):1709-1719. DOI: 10.1016/S1470-2045(16)30500-9. View

Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C . Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo.... J Clin Oncol. 2007; 25(13):1670-6. DOI: 10.1200/JCO.2006.09.0928. View

Azhdarzadeh M, Atyabi F, Saei A, Shiri Varnamkhasti B, Omidi Y, Fateh M . Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer. Colloids Surf B Biointerfaces. 2016; 143:224-232. DOI: 10.1016/j.colsurfb.2016.02.058. View

Kirui D, Koay E, Guo X, Cristini V, Shen H, Ferrari M . Tumor vascular permeabilization using localized mild hyperthermia to improve macromolecule transport. Nanomedicine. 2013; 10(7):1487-96. PMC: 4025989. DOI: 10.1016/j.nano.2013.11.001. View

Lee D, Kim J, Lee Y, Lee S, Miao W, Kim H . Black Pigment Gallstone Inspired Platinum-Chelated Bilirubin Nanoparticles for Combined Photoacoustic Imaging and Photothermal Therapy of Cancers. Angew Chem Int Ed Engl. 2017; 56(44):13684-13688. DOI: 10.1002/anie.201707137. View

Wang L, Shi J, Jia X, Liu R, Wang H, Wang Z . NIR-/pH-Responsive drug delivery of functionalized single-walled carbon nanotubes for potential application in cancer chemo-photothermal therapy. Pharm Res. 2013; 30(11):2757-71. DOI: 10.1007/s11095-013-1095-3. View

10.

Jastrzebska A, Kurtycz P, Olszyna A . Recent advances in graphene family materials toxicity investigations. J Nanopart Res. 2012; 14(12):1320. PMC: 3517804. DOI: 10.1007/s11051-012-1320-8. View

11.

Nozawa H, Takiyama H, Hasegawa K, Kawai K, Hata K, Tanaka T . Adjuvant chemotherapy improves prognosis of resectable stage IV colorectal cancer: a comparative study using inverse probability of treatment weighting. Ther Adv Med Oncol. 2019; 11:1758835919838960. PMC: 6469283. DOI: 10.1177/1758835919838960. View

12.

Stintzing S, Modest D, Rossius L, Lerch M, Fischer von Weikersthal L, Decker T . FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial. Lancet Oncol. 2016; 17(10):1426-1434. DOI: 10.1016/S1470-2045(16)30269-8. View

13.

Wang F, Liu P, Sun L, Li C, Petrenko V, Liu A . Bio-mimetic nanostructure self-assembled from Au@Ag heterogeneous nanorods and phage fusion proteins for targeted tumor optical detection and photothermal therapy. Sci Rep. 2014; 4:6808. PMC: 4210868. DOI: 10.1038/srep06808. View

14.

Siegel R, Fedewa S, Anderson W, Miller K, Ma J, Rosenberg P . Colorectal Cancer Incidence Patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017; 109(8). PMC: 6059239. DOI: 10.1093/jnci/djw322. View

15.

de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J . Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000; 18(16):2938-47. DOI: 10.1200/JCO.2000.18.16.2938. View

16.

Chua T, Yan T, Saxena A, Morris D . Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg. 2009; 249(6):900-7. DOI: 10.1097/SLA.0b013e3181a45d86. View

17.

Einafshar E, Asl A, Nia A, Mohammadi M, Malekzadeh A, Ramezani M . New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite. Carbohydr Polym. 2018; 194:103-110. DOI: 10.1016/j.carbpol.2018.03.102. View

18.

Ott M, Gogvadze V, Orrenius S, Zhivotovsky B . Mitochondria, oxidative stress and cell death. Apoptosis. 2007; 12(5):913-22. DOI: 10.1007/s10495-007-0756-2. View

19.

Hoang B, Lee H, Reilly R, Allen C . Noninvasive monitoring of the fate of 111In-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imaging. Mol Pharm. 2009; 6(2):581-92. DOI: 10.1021/mp8002418. View

20.

Tsai M, Peng C, Yang S, Shieh M . Photothermal, Targeting, Theranostic Near-Infrared Nanoagent with SN38 against Colorectal Cancer for Chemothermal Therapy. Mol Pharm. 2017; 14(8):2766-2780. DOI: 10.1021/acs.molpharmaceut.7b00315. View